News
The FDA will begin promoting computer-based and lab-grown drug testing models to reduce the cost, time, and ethical burden of drug testing.
AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
UAV Corp. (OTC: UMAV) announced today that its subsidiary, Skyborne Technology, will conduct a scheduled inflation test of ...
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
10d
Pharmaceutical Technology on MSNFDA to phase out animal testing with AI and lab-based modelsThe FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.
The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...
Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results